NewEdge Wealth’s ResMed RMD Stock Holding History

NewEdge Wealth’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,282	Closed	-$791K	–	1262
2025 Q4	$791K	Buy	3,282 +1,096	+50%	+$280K	0.01%	696
2025 Q3	$536K	Sell	2,186 -2,350	-52%	-$642K	0.01%	726
2025 Q2	$1.27M	Buy	+4,536	New	+$1.08M	0.02%	478

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

NewEdge Wealth's RMD Position: Q1 2026 in Review

NewEdge Wealth sold out of ResMed (RMD) in Q1 2026, closing a stake of 3,282 shares — an estimated $791K sold.

NewEdge Wealth first reported a position in RMD in Q2 2025 and held it in 3 quarters. The position peaked at $1.27M in Q2 2025. 941 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

NewEdge Wealth reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
NewEdge Wealth sold 3,282 ResMed shares in Q1 2026, an estimated $791K.
NewEdge Wealth first reported a position in ResMed in Q2 2025 and held it in 3 quarters.
NewEdge Wealth's ResMed position peaked at $1.27M in Q2 2025.
941 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.